Due to the complications that result from a dysregulated complement system with its many components in the pathogenesis of AMD, which is not the focus of this review, we will concentrate on introducing selected SNPs in CFH, CFB, and C3 as examples for CRISPR manipulation of SNPs in these genes as a therapeutic strategy for AMD treatment. Here, CFH is linked to age-related macular degeneration.